Bal Pharma Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: BALPHARMA BSE: 524824

About Bal Pharma Limited

No company profile on record yet.

Key facts

BSE symbol524824
NSE symbolBALPHARMA
ISININE083D01012
CINL85110KA1987PLC008368
Listing date8 May 2006
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorParameshwar G Bhat (Parameshwar G Bhat)
Registered office21-22, BOMMASANDRA, INDUSTRIAL AREA, Bommasandra Industrial Estate, Bangalore, Bangalore South, Karnataka, India, 560099
Registrar & transfer agentMUFG Intime India Private Limited C-101, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai - 400083, India.

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)313†305†342†305†287†
Net profit—81069†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
HIMESH VIRUPAKSHYAExecutive DirectorJune 30, 2026
SHAILESH SIROYAExecutive DirectorJune 30, 2026
JATISH SHETHIndependent DirectorJune 30, 2026
MUKESH BHEEKAMCHANDIndependent DirectorJune 30, 2026
NICOLA NEELADRIIndependent DirectorJune 30, 2026
RAVINDRA KUMAR KOTHARINon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.